Company intelligence / Profile preview

Galenoai

Ownership: Private
Development stage: Commercial

Overview

Galenoai ApS is a private UK-based company founded in 2024 with fewer than 10 employees. The company operates in the life sciences/biotech space, focusing on translational medicine and leveraging technology platforms—likely artificial intelligence—for R&D decision-making. As of March 2025, there are no publicly disclosed clinical results or active drug programs.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Galenoai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galenoai.

Explore the full profile